Specialty Chemicals Manufacturer Raises INR 600 Crore in QIP
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
What happened
Neogen Chemicals Limited, a manufacturer of specialty bromine chemicals, completed its first Qualified Institutions Placement (QIP) of equity shares. The issue raised approximately INR 600 crore and was oversubscribed by more than 6.5 times. The company allotted 26,60,753 equity shares at an issue price of INR 2,255 per share.
From equitybulls.com, livemint.com
Why it matters
The capital raise is intended to reduce Neogen Chemicals Limited's outstanding indebtedness and debt servicing costs, thereby improving its debt-to-equity ratio. This financial flexibility is intended to fund future business requirements and growth opportunities.
From equitybulls.com
Who's involved
- SBI Life InsuranceParticipated as an institutional investor in the QIP of Neogen Chemicals Limited.
- Abu Dhabi Investment AuthorityParticipated as an institutional investor in the successful QIP of Neogen Chemicals Limited.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- SBI Life InsuranceSpeculative
SBI Life Insurance might see changes in its capital deployment and investment portfolio.
- Abu Dhabi Investment AuthoritySpeculative
Abu Dhabi Investment Authority might see changes in its capital deployment and investment portfolio.
- bromineSpeculative
The successful capital raise could strengthen the balance sheet of the producing company, impacting the supply of bromine.
Keep exploring
The entities involved
-
SBI Life Insurance
Japanese insurance company
-
bromine
chemical element with symbol Br and atomic number 35
-
Abu Dhabi Investment Authority
sovereign wealth fund
Related events
- Gulf Resources, Inc., a leading manufacturer of bromine, is operating in China and reported increased sales on August 14, 2025.
- Goldman Sachs, Abu Dhabi Investment Authority, and Vanguard are involved in an IPO anchor book as global institutional investors.
- NeoGen's operations are tied to chemicals, and conflict in West Asia is driving sequential price increases for bromine.